Zhang LM - Search Results

1

Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.

Wang CL, Li Y, Yue DS, Zhang LM, Zhang ZF, Sun BS. Wang CL, et al. Among authors: zhang zf, zhang lm. World J Surg. 2012 Feb;36(2):455-62. doi: 10.1007/s00268-011-1360-8. World J Surg. 2012. PMID: 22187129

2

[Clinical and prognostic analysis of skip N2 metastases in stage IIIA-N2 non-small cell lung cancer].

Zhang LM, Zhang ZF, Wang CL. Zhang LM, et al. Among authors: zhang zf. Zhonghua Wai Ke Za Zhi. 2010 May 15;48(10):780-3. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20646498 Chinese.

3

[A clinical and prognostic retrospective analysis of IIIA-N2 non-small cell lung cancer].

Zhang LM, Liu XZ, Zhang ZF, Wang CL, Zhu JQ, Yue DS. Zhang LM, et al. Among authors: zhang zf. Zhonghua Wai Ke Za Zhi. 2010 May 1;48(9):690-3. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20646553 Chinese.

4

[Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].

Li Y, Sun BS, Zhang ZF, Zhang LM, Wang CL. Li Y, et al. Among authors: zhang zf, zhang lm. Zhonghua Yi Xue Za Zhi. 2011 Jun 28;91(24):1682-6. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21914316 Chinese.

5

Combined Erlotinib and Cetuximab overcome the acquired resistance to epidermal growth factor receptors tyrosine kinase inhibitor in non-small-cell lung cancer.

Wang M, Zhao J, Zhang LM, Li H, Yu JP, Ren XB, Wang CL. Wang M, et al. Among authors: zhang lm. J Cancer Res Clin Oncol. 2012 Dec;138(12):2069-77. doi: 10.1007/s00432-012-1291-2. Epub 2012 Jul 22. J Cancer Res Clin Oncol. 2012. PMID: 22821179

6

The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis.

Wang C, Su Y, Zhang L, Wang M, You J, Zhao X, Zhang Z, Liu J, Hao X. Wang C, et al. PLoS One. 2012;7(9):e38046. doi: 10.1371/journal.pone.0038046. Epub 2012 Sep 26. PLoS One. 2012. PMID: 23049725 Free PMC article.

7

[Diagnostic value of (18)F-FDG PET/CT imaging plus serum tumor marker assays for pulmonary lesions and clinical significance of SUVmax].

Zhang TM, Zhang LM, Liu Y, Zhang ZF, Wang CL. Zhang TM, et al. Among authors: zhang zf, zhang lm. Zhonghua Yi Xue Za Zhi. 2012 Nov 6;92(41):2901-4. Zhonghua Yi Xue Za Zhi. 2012. PMID: 23328236 Chinese.

8

[Epithelial growth factor receptor mutation status to the effective of survival in non-small cell lung cancer after surgery].

Liu Y, Zhu JQ, Zhang LM, Zhang TM, Zhang ZF, Wang CL. Liu Y, et al. Among authors: zhang tm, zhang zf, zhang lm. Zhonghua Wai Ke Za Zhi. 2012 Dec;50(12):1082-6. Zhonghua Wai Ke Za Zhi. 2012. PMID: 23336484 Chinese.

9

Expressions of CLDN1 and insulin-like growth factor 2 are associated with poor prognosis in stage N2 non-small cell lung cancer.

Zhang ZF, Pei BX, Wang AL, Zhang LM, Sun BS, Jiang RC, Wang CL. Zhang ZF, et al. Among authors: zhang lm. Chin Med J (Engl). 2013;126(19):3668-74. Chin Med J (Engl). 2013. PMID: 24112161

10

Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer.

Li C, Hao L, Li Y, Wang S, Chen H, Zhang L, Ke B, Yin Y, Suo H, Sun B, Zhang B, Wang C. Li C, et al. PLoS One. 2014 Sep 8;9(9):e107276. doi: 10.1371/journal.pone.0107276. eCollection 2014. PLoS One. 2014. PMID: 25198510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,077 results

Search Page

Filters